Skip to main contentYou have permission to edit this article.EditHomeSearchNewsCoronavirusWeatherSportsFeaturesVideoWatchContactNew York (CNN) — Snack and beverage maker PepsiCo has so far seen “negligible” impact on its business from drugs used for weight loss or diabetes, CEO Ramon Laguarta said during an analyst call Tuesday.Still, he said, the company is keeping an eye on them: “We’re observing the growth of these new drugs and its potential impact.”Some food analysts have warned that long-term adoption of semaglutide drugs like Ozempic and Wegovy, which generally work by suppressing...…Skip to main contentYou have permission to edit this article.EditHomeSearchNewsCoronavirusWeatherSportsFeaturesVideoWatchContactNew York (CNN) — Snack and beverage maker PepsiCo has so far seen “negligible” impact on its business from drugs used for weight loss or diabetes, CEO Ramon Laguarta said during an analyst call Tuesday.Still, he said, the company is keeping an eye on them: “We’re observing the growth of these new drugs and its potential impact.”Some food analysts have warned that long-term adoption of semaglutide drugs like Ozempic and Wegovy, which generally work by suppressing...WW…